Riskpilot← Back to searchSign inGet full accessbyLink ApS
APSActiveCVR 40568158Østre Alle 6Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20197 employeeswww.bylink.dk
Revenue 2025
DKK 989K
+9% vs 2024
EBITDA margin
8.2%
+130% vs 2024
Equity ratio
47.9%
Financial strength
Net profit 2025
DKK 61K
+141% vs 2024
| Revenue | DKK 989K | +9% |
| EBITDA | DKK 81K | +130% |
| Net profit | DKK 61K | +141% |
| Total assets | DKK 859K | +69% |
| Equity | DKK 412K | +17% |
| Employees | 7 | — |
Legal name
byLink ApS
CVR number
40568158
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
7. juni 2019
Share capital
DKK 40.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene eller af den samlede direktion.
Company purpose
Selskabets formål er at levere konsulentydelser indenfor sundhedsinnovation samt slag af fysiske produkter til sundhedssektoren eller anden dermed efter direktionens skøn beslægtet virksomhed.
Address
Østre Alle 6
Phone
+4552113009
Email
info@bylink.dk
Website
www.bylink.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 681 | 551 | 999 | 956 | 910 | 989 |
| Staff expenses | -592 | -548 | -774 | -898 | -875 | -908 |
| EBITDA | 89 | 4 | 225 | 58 | 35 | 81 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 89 | 4 | 225 | 58 | 35 | 81 |
| Net financials | -1 | -1 | 0 | -0 | -1 | -0 |
| Profit before tax | 87 | 3 | 225 | 58 | 34 | 80 |
| Tax | 20 | 2 | 50 | 15 | 9 | 19 |
| Net profit | 67 | 1 | 175 | 42 | 25 | 61 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 333 | 197 | 456 | 439 | 509 | 859 |
| Equity | 107 | 108 | 283 | 325 | 351 | 412 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 226 | 89 | 173 | 114 | 158 | 447 |
| Total debt | 226 | 89 | 173 | 114 | 158 | 447 |
EBITDA margin
8.2%
This company
15.8%
Market median
-48% vs market
20202025
Equity ratio
47.9%
This company
38.2%
Market median
+25% vs market
20202025
Return on equity
14.9%
This company
18.4%
Market median
+19% vs market
20202025
Net profit margin
6.2%
This company
8.1%
Market median
-23% vs market
20202025
Asset turnover
1.15×
This company
1.12×
Market median
+3% vs market
20202025
Debt / equity
1.09×
This company
0.62×
Market median
-76% vs market
20202025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-06-07 – 2020-09-30
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2023 | — | — | |
| Deputy Chairman | 2023 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Canais Holding ApS | Company | 50.0% | 50.0% | 2019 |
B Innovation ApS | Company | 50.0% | 50.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
B Innovation ApS
byLink ApS Board members of byLink ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Flemming Eriksen | Board of Directors | 0 companies |
| Martin Rask Bonnen | Chairman | 0 companies |
| Line Bluhme | Chairman | 0 companies |
| Liza Haslund-Larsen | Deputy Chairman | 0 companies |
| Heidi Søgaard Hvistendahl | Board of Directors | 0 companies |